Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2018 Jan;141(1):104-109.e3.
doi: 10.1016/j.jaci.2017.03.034. Epub 2017 Apr 22.

Clinical predictors of remission and persistence of adult-onset asthma

Affiliations
Clinical Trial

Clinical predictors of remission and persistence of adult-onset asthma

Guus A Westerhof et al. J Allergy Clin Immunol. 2018 Jan.

Abstract

Background: Adult-onset asthma is an important but relatively understudied asthma phenotype and little is known about its natural course and prognosis. The remission rate is believed to be low, and it is still obscure which factors predict remission or persistence of the disease.

Objective: This study sought to determine the remission rate and identify predictors of persistence and remission of adult-onset asthma.

Methods: Two hundred adult patients with recently diagnosed (<1 year) asthma were recruited from secondary and tertiary pulmonary clinics and prospectively followed for 5 years. Clinical, functional, and inflammatory parameters were assessed at baseline and at yearly visits. Asthma remission was defined as absence of asthma symptoms for ≥1 year and no asthma medication use for ≥1 year. Descriptive statistics and logistic regression analysis were performed.

Results: Five-year follow-up data of 170 patients (85%) was available. Of these, 27 patients (15.9%) experienced asthma remission. Patients with asthma persistence were older, had worse asthma control, required higher doses of inhaled corticosteroids, had more severe airway hyperresponsiveness, more often nasal polyps, and higher levels of blood neutrophils as compared to patients who experienced clinical remission. In a multivariable logistic regression analysis, only moderate to severe bronchial hyperresponsiveness and nasal polyps were independent predictors of asthma persistence. Patients with these 2 characteristics had <1% chance of asthma remission.

Conclusions: One in 6 patients with adult-onset asthma experiences remission within the first 5 years of the disease. In patients with moderate to severe bronchial hyperresponsiveness and nasal polyposis, the chance of remission is close to zero.

Keywords: Adult-onset; asthma; clinical predictors; persistence; prognosis; prospective study; remission.

PubMed Disclaimer

Comment in

  • Comments on clinical predictors of remission and persistence of adult-onset asthma.
    Ayubi E, Safiri S. Ayubi E, et al. J Allergy Clin Immunol. 2018 Jan;141(1):458-459. doi: 10.1016/j.jaci.2017.08.010. Epub 2017 Sep 28. J Allergy Clin Immunol. 2018. PMID: 28967479 No abstract available.
  • Reply.
    Westerhof GA, Bel EH. Westerhof GA, et al. J Allergy Clin Immunol. 2018 Jan;141(1):459. doi: 10.1016/j.jaci.2017.07.037. Epub 2017 Sep 28. J Allergy Clin Immunol. 2018. PMID: 28967480 No abstract available.
  • Identification of remission in adult-onset asthma.
    Busse P, Wechsler ME. Busse P, et al. Lancet Respir Med. 2018 Jun;6(6):417-418. doi: 10.1016/S2213-2600(18)30175-9. Epub 2018 Apr 23. Lancet Respir Med. 2018. PMID: 29699818 No abstract available.

Similar articles

Cited by

Publication types